Company Summary:
Tessera Therapeutics is pioneering Gene Writing™— a new biotechnology designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, thereby curing diseases at their source. Gene Writing holds the potential to become a new category in genetic medicine, building upon recent breakthroughs in gene therapy and gene editing while eliminating important limitations in their reach, utilization, and efficacy. Tessera Therapeutics was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability.
Position Summary:
Tessera Therapeutics is seeking a highly motivated in vivo scientist with robust experience in drug discovery and development to help support our in vivo delivery discovery program teams. You will work with a cross-functional team to help to design the in vivo studies and have the primary responsibility for executing studies to optimize the delivery system of our Gene Writers to edit immune cells and stem cells in vivo.
Key Responsibilities:
Qualifications:
More About Flagship Pioneering
Flagship Pioneering conceives, creates, resources, and develops first-in-category life sciences companies to transform human health and sustainability. Since its launch in 2000, the firm has, through its Flagship Labs unit, applied its unique hypothesis-driven innovation process to originate and foster more than 100 scientific ventures, resulting in over $50B in aggregate value. To date, Flagship has deployed over $2.2B in capital toward the founding and growth of its pioneering companies alongside more than $18B of follow-on investments from other institutions. The current Flagship ecosystem comprises 41 transformative companies, including Axcella Health (NASDAQ: AXLA), Denali Therapeutics (NASDAQ: DNLI), Evelo Biosciences (NASDAQ: EVLO), Foghorn Therapeutics (NASDAQ: FHTX), Indigo Ag, Kaleido Biosciences (NASDAQ: KLDO), Moderna (NASDAQ: MRNA), Rubius Therapeutics (NASDAQ: RUBY), Sana Biotechnology, Seres Therapeutics (NASDAQ: MCRB), and Sigilon Therapeutics (NASDAQ: SGTX).
Flagship Pioneering and our ecosystem companies are committed to equal employment opportunity regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, gender identity or Veteran status.
Recruitment & Staffing Agencies: Flagship Pioneering and its affiliated Flagship Lab companies (collectively, “FSP”) do not accept unsolicited resumes from any source other than candidates. The submission of unsolicited resumes by recruitment or staffing agencies to FSP or its employees is strictly prohibited unless contacted directly by Flagship Pioneering’s internal Talent Acquisition team. Any resume submitted by an agency in the absence of a signed agreement will automatically become the property of FSP, and FSP will not owe any referral or other fees with respect thereto.
ECU Health About ECU Health EastCare ECU Health EastCare provides critical care air and ground transportation service and is the...
Apply For This JobInterDent is a leading Dental Service Organization (DSO) supporting 175 practices under the brands “Gentle Dental” and “SmileKeepers.” We support...
Apply For This JobBuscamos uma pessoa Analista de Customer Success – Grandes Contas para transformar a empregabilidade do Brasil com o time da...
Apply For This JobMartiDerm, tú eres la fórmula MartiDerm es una empresa líder en dermo-cosmética, destacando por la creación de la categoría de...
Apply For This JobDirector of GTM & Industry Solutions(Austin, TX) About Atmosphere:Atmosphere is the world’s #1 streaming service for businesses, offering 65+ channels...
Apply For This JobR232766 Description About this role Position Overview The Solutions Strategy team works within MASS to coordinate and lead the implementation...
Apply For This Job